Las Vegas, Nv. 4/26/2007 08:28 PM GMT (TransWorldNews)
StemCell Pharma, Inc. (SCPI) had submitted to the Commissioner of Patents, Alexandria, Va. evidence to support proof of concept/priority regarding this invention.
SCPI has now two years to submit a patent application, but that will be done much sooner. Some non-confidential information regarding this Invention will be released during the European Stem Cell Congress, May 1-3, 2007 at the Landmark Hotel, London, UK. SCPI has exhibit #8.
Alfred T. Sapse MD (r)
Tel. (702) 383-5893
Fax ((702) 733-9505